- Job postings
OstomyCure AS Appoints new Chief Medical Officer
OstomyCure today announced the appointment of Cindy Wong, M.D. as Chief Medical Officer (CMO). Dr Wong brings a wealth of experience to the company, especially in Post Market Surveys and FDA submissions.
Message from CEO Ostomycure Dr Benedict Broenniman M.D.
OstomyCure AS has been published in The Ileostomy & Internal Pouch Support Groups latest issue of the IA Journal.
OstomyCure AS engages Morten Gunvad, currently founder and Head of GP Consulting GmbH, as Chief Commercial Officer of the TIES® System.
The TIES® Implant and Lid will be represented at Almedalsveckan, an annual political event taking place in Visby, Sweden.
Aimed to dramatically improve the patient’s quality of life, the TIES® System, a new concept in continent ileostomy receives CE marking.
Today, OstomyCure is very pleased to announce that the TIES® System has received approval for CE marking from our Notified Body.
Comprising an implantable medical device, the TIES® System requires approval from a Notified Body in order to obtain CE marking and to be marketed in Europe.
The ongoing TIES® clinical study is moving forward and is now fully enrolled with the planned number of patients.
OstomyCure certification was upgraded to a higher level.